These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38980361)

  • 1. Antifungal prophylaxis of COVID-19 associated pulmonary aspergillosis in ventilated patients: one solution does not fit all.
    Prattes J; Giacobbe DR; Bassetti M; Gangneux JP; Hoenigl M;
    Intensive Care Med; 2024 Aug; 50(8):1375-1377. PubMed ID: 38980361
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of acquired invasive fungal infection with decontamination regimen in mechanically ventilated ICU patients: a pre/post observational study.
    Massart N; Reizine F; Dupin C; Legay F; Legris E; Cady A; Rieul G; Barbarot N; Magahlaes E; Fillatre P
    Infect Dis (Lond); 2023 Apr; 55(4):263-271. PubMed ID: 36694427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the entire landscape of antifungal immune response to COVID-19-associated pulmonary aspergillosis.
    Reizine F; Tadié JM; Grégoire M; Tarte K; Gangneux JP
    Lancet Microbe; 2024 Aug; 5(8):100861. PubMed ID: 38670134
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a deadly complication.
    Kosmidis C; Hoenigl M
    Thorax; 2023 Dec; 79(1):9-10. PubMed ID: 37940199
    [No Abstract]   [Full Text] [Related]  

  • 5. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
    Koehler P; Bassetti M; Chakrabarti A; Chen SCA; Colombo AL; Hoenigl M; Klimko N; Lass-Flörl C; Oladele RO; Vinh DC; Zhu LP; Böll B; Brüggemann R; Gangneux JP; Perfect JR; Patterson TF; Persigehl T; Meis JF; Ostrosky-Zeichner L; White PL; Verweij PE; Cornely OA; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Lancet Infect Dis; 2021 Jun; 21(6):e149-e162. PubMed ID: 33333012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
    Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
    Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.
    Lamoth F; Lewis RE; Walsh TJ; Kontoyiannis DP
    J Infect Dis; 2021 Nov; 224(10):1631-1640. PubMed ID: 33770176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
    Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M
    Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of COVID-19-associated pulmonary aspergillosis: time for a nuanced approach to antifungal prophylaxis?
    Hoenigl M; Prattes J
    Lancet Respir Med; 2024 Mar; 12(3):183-185. PubMed ID: 38185136
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19-associated pulmonary aspergillosis in a Japanese man: A case report.
    Imoto W; Himura H; Matsuo K; Kawata S; Kiritoshi A; Deguchi R; Miyashita M; Kaga S; Noda T; Yamamoto K; Yamada K; Uchida K; Nishimura T; Yamamoto H; Mizobata Y; Kakeya H
    J Infect Chemother; 2021 Jun; 27(6):911-914. PubMed ID: 33674201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.
    Meijer EFJ; Dofferhoff ASM; Hoiting O; Meis JF
    Mycoses; 2021 Apr; 64(4):457-464. PubMed ID: 33569857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.
    Permpalung N; Chiang TP; Massie AB; Zhang SX; Avery RK; Nematollahi S; Ostrander D; Segev DL; Marr KA
    Clin Infect Dis; 2022 Jan; 74(1):83-91. PubMed ID: 33693551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit.
    Fumarola B; Signorini L; Lorenzotti S; Lanza P; Saccani B; Van Hauwermeiren E; Mulè A; Piva S; Rota M; Zuccalà F; Rasulo FA; Filippini M; Bertazzoli A; Del Fabro G; Matteelli A
    Infection; 2024 Aug; 52(4):1459-1468. PubMed ID: 38530518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis.
    Armstrong-James D; Youngs J; Bicanic T; Abdolrasouli A; Denning DW; Johnson E; Mehra V; Pagliuca T; Patel B; Rhodes J; Schelenz S; Shah A; van de Veerdonk FL; Verweij PE; White PL; Fisher MC
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32703771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis.
    Le Daré B; Boglione-Kerrien C; Reizine F; Gangneux JP; Bacle A
    Crit Care; 2021 Apr; 25(1):152. PubMed ID: 33879175
    [No Abstract]   [Full Text] [Related]  

  • 17. [What is new … in the treatment of invasive mycosis: COVID-19-associated pulmonary aspergillosis].
    Scharf C; Zoller M; Liebchen U
    Anaesthesist; 2021 May; 70(5):432-433. PubMed ID: 33635372
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.
    Salmanton-García J; Sprute R; Stemler J; Bartoletti M; Dupont D; Valerio M; Garcia-Vidal C; Falces-Romero I; Machado M; de la Villa S; Schroeder M; Hoyo I; Hanses F; Ferreira-Paim K; Giacobbe DR; Meis JF; Gangneux JP; Rodríguez-Guardado A; Antinori S; Sal E; Malaj X; Seidel D; Cornely OA; Koehler P;
    Emerg Infect Dis; 2021; 27(4):1077-1086. PubMed ID: 33539721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis.
    Soriano MC; Narváez-Chávez G; López-Olivencia M; Fortún J; de Pablo R
    Intensive Care Med; 2022 Mar; 48(3):360-361. PubMed ID: 34940907
    [No Abstract]   [Full Text] [Related]  

  • 20. Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels.
    Bakir Ekinci P; Kara E; Er AG; Inkaya AC; Demirkan K; Uzun O
    Br J Clin Pharmacol; 2022 Mar; 88(3):1387-1391. PubMed ID: 34174111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.